OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
Jinfen Wang, Zijun Y. Xu‐Monette, Kausar J. Jabbar, et al.
American Journal Of Pathology (2017) Vol. 187, Iss. 8, pp. 1700-1716
Open Access | Times Cited: 52
Jinfen Wang, Zijun Y. Xu‐Monette, Kausar J. Jabbar, et al.
American Journal Of Pathology (2017) Vol. 187, Iss. 8, pp. 1700-1716
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
AKT as a Therapeutic Target for Cancer
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 656
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 656
AKT and ERK dual inhibitors: The way forward?
Zhe Cao, Qianjin Liao, Min Su, et al.
Cancer Letters (2019) Vol. 459, pp. 30-40
Open Access | Times Cited: 177
Zhe Cao, Qianjin Liao, Min Su, et al.
Cancer Letters (2019) Vol. 459, pp. 30-40
Open Access | Times Cited: 177
Genetic alterations and their clinical implications in DLBCL
Yi Miao, L. Jeffrey Medeiros, Yong Li, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 634-652
Closed Access | Times Cited: 176
Yi Miao, L. Jeffrey Medeiros, Yong Li, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 634-652
Closed Access | Times Cited: 176
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
Isha Kapoor, Yue Li, Arishya Sharma, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 12
Open Access | Times Cited: 69
Isha Kapoor, Yue Li, Arishya Sharma, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 12
Open Access | Times Cited: 69
Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling
Ji-Hyun Chung, Vrajesh Karkhanis, Robert A. Baiocchi, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 19, pp. 7692-7710
Open Access | Times Cited: 65
Ji-Hyun Chung, Vrajesh Karkhanis, Robert A. Baiocchi, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 19, pp. 7692-7710
Open Access | Times Cited: 65
SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19
Sabina Sahanic, Richard Hilbe, Christina Dünser, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21893-e21893
Open Access | Times Cited: 18
Sabina Sahanic, Richard Hilbe, Christina Dünser, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21893-e21893
Open Access | Times Cited: 18
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Xiaoxiao Wang, Xin Cao, Ruifang Sun, et al.
Neoplasia (2018) Vol. 20, Iss. 6, pp. 574-593
Open Access | Times Cited: 58
Xiaoxiao Wang, Xin Cao, Ruifang Sun, et al.
Neoplasia (2018) Vol. 20, Iss. 6, pp. 574-593
Open Access | Times Cited: 58
Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
Yi Miao, L. Jeffrey Medeiros, Zijun Y. Xu‐Monette, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 46
Yi Miao, L. Jeffrey Medeiros, Zijun Y. Xu‐Monette, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 46
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
Hui Zhou, Zijun Y. Xu‐Monette, Ling Xiao, et al.
Blood Cancer Journal (2020) Vol. 10, Iss. 5
Open Access | Times Cited: 42
Hui Zhou, Zijun Y. Xu‐Monette, Ling Xiao, et al.
Blood Cancer Journal (2020) Vol. 10, Iss. 5
Open Access | Times Cited: 42
Altered pathways and targeted therapy in double hit lymphoma
Yuxin Zhuang, Jinxin Che, Meijuan Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Yuxin Zhuang, Jinxin Che, Meijuan Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 20
DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma
Simar Pal Singh, Michelle D van den Beukel, Sjoerd van Deventer, et al.
(2025)
Open Access
Simar Pal Singh, Michelle D van den Beukel, Sjoerd van Deventer, et al.
(2025)
Open Access
DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma
Simar Pal Singh, Michelle D van den Beukel, Sjoerd van Deventer, et al.
(2025)
Open Access
Simar Pal Singh, Michelle D van den Beukel, Sjoerd van Deventer, et al.
(2025)
Open Access
SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
Jacob Batham, Pek Siew Lim, Sudha Rao
Cancers (2019) Vol. 11, Iss. 8, pp. 1143-1143
Open Access | Times Cited: 31
Jacob Batham, Pek Siew Lim, Sudha Rao
Cancers (2019) Vol. 11, Iss. 8, pp. 1143-1143
Open Access | Times Cited: 31
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
Manman Deng, Zijun Y. Xu‐Monette, Lan V. Pham, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 2, pp. 249-260
Open Access | Times Cited: 30
Manman Deng, Zijun Y. Xu‐Monette, Lan V. Pham, et al.
Molecular Cancer Research (2020) Vol. 19, Iss. 2, pp. 249-260
Open Access | Times Cited: 30
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
Liu Liu, Hui Yan, Maomei Ruan, et al.
Cancer Science (2021) Vol. 112, Iss. 8, pp. 3083-3098
Open Access | Times Cited: 26
Liu Liu, Hui Yan, Maomei Ruan, et al.
Cancer Science (2021) Vol. 112, Iss. 8, pp. 3083-3098
Open Access | Times Cited: 26
Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562
Nehad M. El‐Dydamony, Rana M. Abdelnaby, Rasha Abdelhady, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 895-911
Open Access | Times Cited: 16
Nehad M. El‐Dydamony, Rana M. Abdelnaby, Rasha Abdelhady, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 895-911
Open Access | Times Cited: 16
Protein kinase inhibitors for acute leukemia
Ling Yuan, Qing Xie, Zikang Zhang, et al.
Biomarker Research (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 31
Ling Yuan, Qing Xie, Zikang Zhang, et al.
Biomarker Research (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 31
Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphoma
Maria Bhatti, Thomas Ippolito, Cory Mavis, et al.
Oncotarget (2018) Vol. 9, Iss. 31, pp. 21820-21830
Open Access | Times Cited: 31
Maria Bhatti, Thomas Ippolito, Cory Mavis, et al.
Oncotarget (2018) Vol. 9, Iss. 31, pp. 21820-21830
Open Access | Times Cited: 31
KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation
Yu‐Shui Ma, Ting‐Miao Wu, Bin Qian, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 8, pp. 4040-4052
Open Access | Times Cited: 19
Yu‐Shui Ma, Ting‐Miao Wu, Bin Qian, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 8, pp. 4040-4052
Open Access | Times Cited: 19
Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma
Suliman A. Alsagaby
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2261-2281
Open Access | Times Cited: 13
Suliman A. Alsagaby
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2261-2281
Open Access | Times Cited: 13
CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma
Ying Li, Xiangxiang Zhou, Ya Zhang, et al.
Cell Cycle (2019) Vol. 18, Iss. 4, pp. 379-394
Open Access | Times Cited: 20
Ying Li, Xiangxiang Zhou, Ya Zhang, et al.
Cell Cycle (2019) Vol. 18, Iss. 4, pp. 379-394
Open Access | Times Cited: 20
Developmental profiling of microRNAs in the human embryonic inner ear
Duncan M. Chadly, Jennifer M. Best, Cong Ran, et al.
PLoS ONE (2018) Vol. 13, Iss. 1, pp. e0191452-e0191452
Open Access | Times Cited: 19
Duncan M. Chadly, Jennifer M. Best, Cong Ran, et al.
PLoS ONE (2018) Vol. 13, Iss. 1, pp. e0191452-e0191452
Open Access | Times Cited: 19
Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use
Qingyuan Qu, Ying Li, Xiaosheng Fang, et al.
Biology Direct (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Qingyuan Qu, Ying Li, Xiaosheng Fang, et al.
Biology Direct (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies
Isha Kapoor, Juraj Bodo, Brian T. Hill, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 13
Isha Kapoor, Juraj Bodo, Brian T. Hill, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 13
Biological roles of THRAP3, STMN1 and GNA13 in human blood cancer cells
Suliman A. Alsagaby
3 Biotech (2024) Vol. 14, Iss. 10
Closed Access | Times Cited: 1
Suliman A. Alsagaby
3 Biotech (2024) Vol. 14, Iss. 10
Closed Access | Times Cited: 1
